HCPCS code J1326 — Inj, zolbetuximab-clzb, 2 mg. Status: Active. Effective Jul 1, 2025. Source: CMS HCPCS Level II.

J1326

Active

Inj, zolbetuximab-clzb, 2 mg

Injection, zolbetuximab-clzb, 2 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0747

MUE — Medically Unlikely Edits

Maximum units of J1326 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 1200
Practitioner Services 1200

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00469-3425-10 Vyloy
00469-4425-30 Vyloy

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q3
    Inj, zolbetuximab-clzb, 2 mg